Coherus BioSciences, Inc. (CHRS): Price and Financial Metrics
Coherus BioSciences, Inc. (CHRS)
Today's Latest Price: $18.41 USD
Updated Sep 25 4:00pm
Add CHRS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CHRS Stock Summary
- In terms of twelve month growth in earnings before interest and taxes, Coherus BioSciences Inc is reporting a growth rate of -296.37%; that's higher than merely 6.38% of US stocks.
- Revenue growth over the past 12 months for Coherus BioSciences Inc comes in at 304.37%, a number that bests 97.88% of the US stocks we're tracking.
- The volatility of Coherus BioSciences Inc's share price is greater than that of merely 8.73% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to CHRS, based on their financial statements, market capitalization, and price volatility, are ACMR, SMLR, CPAH, AAT, and TAST.
- CHRS's SEC filings can be seen here. And to visit Coherus BioSciences Inc's official web site, go to www.coherus.com.
CHRS Stock Price Chart Technical Analysis Charts
CHRS Price/Volume Stats
| Current price | $18.41 | 52-week high | $23.06 |
| Prev. close | $17.99 | 52-week low | $10.86 |
| Day low | $17.99 | Volume | 575,271 |
| Day high | $18.68 | Avg. volume | 1,354,268 |
| 50-day MA | $18.73 | Dividend yield | N/A |
| 200-day MA | $18.01 | Market Cap | 1.32B |
Coherus BioSciences, Inc. (CHRS) Company Bio
Coherus Biosciences is a pure-play biosimilar platform company that develops and commercializes high-quality therapeutics for major regulated markets. The company was founded in 2010 and is based in Redwood City, California.
Loading social stream, please wait...